معلومات الاتصال

البريد الإلكتروني: abbas21111981@gmail.com

رقم الهاتف: 07802692099

. عباس عبد الرضا مهيهي الصريفي

  • الشهادات:
  • الاختصاص:
  • الاختصاص الدقيق:
  • اللقب العلمي:
  • السيرة الذاتية:
  • ماجستير
  • الصيدلة
  • كيمياء صيدلانية

Work Experience :

  1. was appointed as a pharmacist training in the Ministry of Health - wasit Health Directorate / Al Karama teaching hospital at 1/2/2006.
  2. In 2007, I was a Pharmacy Division Manager in the Thi-Qar Health Directorate, Al-Rifai Sector Primary Health Care.
  3. In 2011, I was director of the main health center in Qalat Sukker, Thi-Qar Health Directorate.
  4. In 2017, a director of the health centers division in the Thi-Qar Health Directorate, Qalat Sukker Sector Primary Health Care.
  5. In 2015–2017, I am working as an external lecturer at Thi-Qar University, College of Pharmacy, for pharmaceutical chemistry (4th stage).
  6. In 2021–2022, I am working as an external lecturer at Mazaya University College Department of Pharmacy for advanced pharmaceutical analysis (5th stage).
  7. In 2023-2025, I am a member of the teaching staff at the college of Pharmacy, University of Al-Ameed, teaching the following courses:
    • oInorganic pharmaceutical chemistry
    • oOrganic pharmaceutical chemistry I
    • oOrganic pharmaceutical chemistry II
    • Organic pharmaceutical chemistry III
    • Organic pharmaceutical chemistry IV
    • Advanced pharmaceutical analysis

Education :

  1. 2005 BSc in pharmacy college of pharmacy university of Baghdad
  2. 2016 MSc in pharmaceutical chemistry college of pharmacy university of Baghdad
  3. 2022 PhD in pharmaceutical chemistry college of pharmacy university of Baghdad

Languages :

  • Arabic, English — good

Researches

  1. New tolfenamic acid derivatives with hydrazine-1-carbothioamide and 1, 3, 4-oxadiazole moieties targeting VEGFR: Synthesis, in silico studies, and in vitro anticancer assessment‏
  2. Discovery of new fenamate-based derivatives as anticancer agents and potent VEGFR-2 inhibitors: design, synthesis, and in silico study‏
  3. Synthesis, molecular docking studies, and in vitro anticancer evaluation of novel tolfenamic acid derivatives‏
  4. Synthesis of some anticancer agent conjugated to aminoacids through amide bond with expected biological activity‏
Copyright © AlAmeed 2018.All right reserved.Created by AlAmeed University